Epiyangambin is primarily studied for its potential biological activities, particularly in the field of cancer research. It has demonstrated cytotoxic effects against certain cancer cell lines, making it a subject of interest in the development of anticancer agents. Its mechanism may involve the induction of apoptosis and interference with cell cycle progression in tumor cells. Additionally, epiyangambin exhibits anti-inflammatory and antimicrobial properties, suggesting possible applications in treating infections and inflammatory conditions. Due to its natural origin and structural complexity, it also serves as a lead compound for the synthesis of derivatives with enhanced pharmacological profiles. Research remains largely preclinical, focusing on understanding its bioactivity and therapeutic potential.